Vimal Kavuru
Director at Grace Therapeutics.
Raised on Grace Therapeutics filings
$15M
of $30M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 8
- Last filing
- Feb 25, 2025
Company
IV treatment for a rare type of brain bleed
- Investors
- 14
- Still open
- $15M
Grace Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Feb 25, 2025 | Equity | $15M/ $30M | Form D |
- EquityFiled Feb 25, 2025Form D$15M/ $30M
Works with
Prashant KohliChief Executive Officer, Form D signerForm D signerAmresh KumarVP of Program ManagementA. Brian DavisDirectorDr. R. Loch MacdonaldChief Medical OfficerRobert J. DelAversanoVice President, Finance, Principal Financial Officer and Principal Accounting OfficerS. George KottayilDirectorCarrie D'AndreaVP Clinical OperationsEdward NeugeborenDirector
